Status:
COMPLETED
Remission Induction and Sustenance in Graves' Disease 2
Lead Sponsor:
Aalborg University Hospital
Conditions:
Graves Disease
Hyperthyroidism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
ATD therapy for Graves' disease is one of the commonly used options for therapy of the hyperthyroidism. The investigators study how to optimally keep patients in remission.
Detailed Description
A detailed description of patients entering the initial observational phase of the study (RISG1) has been published: Laurberg P, Nygaard B, Andersen S, Carlé A, Karmisholt J, Krejbjerg A, Pedersen IB...
Eligibility Criteria
Inclusion
- Graves hyperthyroidism in remission after ATD
Exclusion
- Age \< 18, severe concomitant disease
Key Trial Info
Start Date :
January 7 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2015
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00796913
Start Date
January 7 2008
End Date
May 15 2015
Last Update
January 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.